SAN DIEGO, Oct. 29, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that it will report financial results for the third quarter and the nine months ended September 30, 2014 on Thursday, November 6, 2014 at 4:00 p.m. Eastern Standard Time (1:00 p.m. Pacific Standard Time).
Trovagene’s senior management team will host a conference call on Thursday, November 6, 2014 at 5:00 p.m. Eastern Standard Time (2:00 p.m. Pacific Standard Time) to discuss the results and update investors on the Company’s progress.
A live webcast of the call will be available online at www.trovagene.investorroom.com/overview. To access the conference call, please dial (887) 347-6081 (domestic), (412) 902-4285 (international), or (855) 669-9657 (Canada), conference ID# 10054927. To access the telephone replay of the call, dial (877) 344-7529 (domestic), (412) 317-0088 (international), or (855) 669-9658 (Canada), replay ID# 10054927. The webcast and telephone replay will be archived on the company’s website following the call.
About Trovagene, Inc.
Headquartered in San Diego, California, Trovagene is leveraging its proprietary technology for the detection and monitoring of cell-free DNA in urine. The Company’s technology detects and quantitates oncogene mutations in cancer patients for improved disease management. Trovagene’s precision cancer monitoring platform is designed to provide important clinical information beyond the current standard of care, and is protected by significant intellectual property including multiple issued patents and pending patent applications globally.
Contact
Investor Relations | Media Relations | |
David Moskowitz and Amy Caterina Investor Relations | Ian Stone Account Director | |
Trovagene, Inc. | Canale Communications, Inc. | |
858-952-7593 | 619-849-5388 | |
Logo - http://photos.prnewswire.com/prnh/20120620/LA28014LOGO
SOURCE Trovagene, Inc.
Help employers find you! Check out all the jobs and post your resume.
